InspireMD director reports four warrant transactions

The reported entries cover two warrant series, with separate acquisition and disposition records at two listed exercise prices.

Rhea-AI Filing Summary

InspireMD, Inc. director Stuka Paul reported four indirect warrant transactions dated September 18, 2026: an acquisition and a disposition each involving Series J and Series K warrants. Each Series J transaction covered 43,750 underlying common shares, and each Series K transaction covered 87,500. The records list exercise prices of $1.3827 per share for the dispositions and $0.7674 per share for the acquisitions. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Other: 262,500 shares

Other 4 txns

Insider Stuka Paul

Role Director

Type	Security	Shares	Price	Value
Other	Series J Warrant (right to buy) F1, F2, F3	43,750	$0.00	$0.00
Other	Series J Warrant (right to buy) F1, F4, F3	43,750	$0.00	$0.00
Other	Series K Warrant (right to buy) F5, F6, F3	87,500	$0.00	$0.00
Other	Series K Warrant (right to buy) F5, F7, F3	87,500	$0.00	$0.00

Holdings After Transaction: Series J Warrant (right to buy) — 87,500 contracts (Indirect, See Footnote); Series K Warrant (right to buy) — 43,750 contracts (Indirect, See Footnote)

Footnotes (7)

1. F1. See Exhibit 99.1; Note 1
2. F2. See Exhibit 99.1; Note 2
3. F3. See Exhibit 99.1; Note 3
4. F4. See Exhibit 99.1; Note 4
5. F5. See Exhibit 99.1; Note 5
6. F6. See Exhibit 99.1; Note 6
7. F7. See Exhibit 99.1; Note 7

Key Figures

Series J shares underlying acquired warrants: 43,750 shares Series J shares underlying disposed warrants: 43,750 shares Series K shares underlying acquired warrants: 87,500 shares +3 more

6 metrics

Series J shares underlying acquired warrants 43,750 shares Transaction dated September 18, 2026

Series J shares underlying disposed warrants 43,750 shares Transaction dated September 18, 2026

Series K shares underlying acquired warrants 87,500 shares Transaction dated September 18, 2026

Series K shares underlying disposed warrants 87,500 shares Transaction dated September 18, 2026

Exercise price listed for acquisitions $0.7674 per share Series J and Series K warrant records

Exercise price listed for dispositions $1.3827 per share Series J and Series K warrant records

Key Terms

Series J Warrant, Series K Warrant

2 terms

Series J Warrant financial

"Series J Warrant (right to buy)"

Series K Warrant financial

"Series K Warrant (right to buy)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What warrant transactions did NSPR director Stuka Paul report?

Stuka Paul reported an acquisition and a disposition for each of two warrant series on September 18, 2026. Each Series J transaction involved 43,750 underlying common shares, and each Series K transaction involved 87,500; the records list $0.7674 and $1.3827 per-share exercise prices for the acquisitions and dispositions, respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/23/2026 - 04:06 PM Accepted by SEC EDGAR 09/23/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stuka Paul

(Last) (First) (Middle)

C/O INSPIREMD, INC.

6303 WATERFORD DISTRICT DRIVE, SUITE 215

(Street)

MIAMI FLORIDA 33126

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
InspireMD, Inc. [ NSPR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series J Warrant (right to buy)	$1.3827	09/18/2026		J(1)			43,750	05/15/2023	(2)	Common Stock	43,750	$0	43,750	I(3)	See Footnote
Series J Warrant (right to buy)	$0.7674	09/18/2026		J(1)		43,750		05/15/2023	(4)	Common Stock	43,750	$0	43,750	I(3)	See Footnote
Series K Warrant (right to buy)	$1.3827	09/18/2026		J(5)			87,500	05/15/2023	(6)	Common Stock	87,500	$0	0	I(3)	See Footnote
Series K Warrant (right to buy)	$0.7674	09/18/2026		J(5)		87,500		05/15/2023	(7)	Common Stock	87,500	$0	43,750	I(3)	See Footnote

Explanation of Responses:

1. See Exhibit 99.1; Note 1

2. See Exhibit 99.1; Note 2

3. See Exhibit 99.1; Note 3

4. See Exhibit 99.1; Note 4

5. See Exhibit 99.1; Note 5

6. See Exhibit 99.1; Note 6

7. See Exhibit 99.1; Note 7

	/s/ Michael Lawless, Attorney-in-Fact for Paul Stuka	09/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)